| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 10057534
[patent_doc_number] => 09096880
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-08-04
[patent_title] => 'Solubility enhancing peptide and use thereof'
[patent_app_type] => utility
[patent_app_number] => 14/275903
[patent_app_country] => US
[patent_app_date] => 2014-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 3233
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14275903
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/275903 | Solubility enhancing peptide and use thereof | May 12, 2014 | Issued |
Array
(
[id] => 12009933
[patent_doc_number] => 09803241
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-10-31
[patent_title] => 'Methods and compositions for determining a graft tolerant phenotype in a subject'
[patent_app_type] => utility
[patent_app_number] => 14/270206
[patent_app_country] => US
[patent_app_date] => 2014-05-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 9
[patent_no_of_words] => 13066
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 138
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14270206
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/270206 | Methods and compositions for determining a graft tolerant phenotype in a subject | May 4, 2014 | Issued |
Array
(
[id] => 10844271
[patent_doc_number] => 08871445
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-10-28
[patent_title] => 'CRISPR-Cas component systems, methods and compositions for sequence manipulation'
[patent_app_type] => utility
[patent_app_number] => 14/259420
[patent_app_country] => US
[patent_app_date] => 2014-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 116
[patent_figures_cnt] => 117
[patent_no_of_words] => 54976
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 99
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14259420
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/259420 | CRISPR-Cas component systems, methods and compositions for sequence manipulation | Apr 22, 2014 | Issued |
Array
(
[id] => 9823331
[patent_doc_number] => 08932814
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-01-13
[patent_title] => 'CRISPR-Cas nickase systems, methods and compositions for sequence manipulation in eukaryotes'
[patent_app_type] => utility
[patent_app_number] => 14/258458
[patent_app_country] => US
[patent_app_date] => 2014-04-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 116
[patent_figures_cnt] => 117
[patent_no_of_words] => 52557
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 117
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14258458
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/258458 | CRISPR-Cas nickase systems, methods and compositions for sequence manipulation in eukaryotes | Apr 21, 2014 | Issued |
Array
(
[id] => 10684422
[patent_doc_number] => 20160030568
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-02-04
[patent_title] => 'COMPOSITIONS CAPABLE OF FACILITATING PENETRATION ACROSS A BIOLOGICAL BARRIER'
[patent_app_type] => utility
[patent_app_number] => 14/258572
[patent_app_country] => US
[patent_app_date] => 2014-04-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 18948
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14258572
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/258572 | COMPOSITIONS CAPABLE OF FACILITATING PENETRATION ACROSS A BIOLOGICAL BARRIER | Apr 21, 2014 | Abandoned |
Array
(
[id] => 9656782
[patent_doc_number] => 20140227787
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-08-14
[patent_title] => 'CRISPR-CAS SYSTEMS AND METHODS FOR ALTERING EXPRESSION OF GENE PRODUCTS'
[patent_app_type] => utility
[patent_app_number] => 14/256912
[patent_app_country] => US
[patent_app_date] => 2014-04-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 46
[patent_figures_cnt] => 46
[patent_no_of_words] => 31049
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14256912
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/256912 | CRISPR-Cas systems and methods for altering expression of gene products | Apr 17, 2014 | Issued |
Array
(
[id] => 10548375
[patent_doc_number] => 09272986
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-03-01
[patent_title] => 'Diacylhydrazine ligands for modulating the expression of exogenous genes in mammalian systems via an ecdysone receptor complex'
[patent_app_type] => utility
[patent_app_number] => 14/254291
[patent_app_country] => US
[patent_app_date] => 2014-04-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38322
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14254291
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/254291 | Diacylhydrazine ligands for modulating the expression of exogenous genes in mammalian systems via an ecdysone receptor complex | Apr 15, 2014 | Issued |
Array
(
[id] => 10694009
[patent_doc_number] => 20160040155
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-02-11
[patent_title] => 'ACTIVATING AN ALTERNATIVE PATHWAY FOR HOMOLOGY-DIRECTED REPAIR TO STIMULATE TARGETED GENE CORRECTION AND GENOME ENGINEERING'
[patent_app_type] => utility
[patent_app_number] => 14/776835
[patent_app_country] => US
[patent_app_date] => 2014-04-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 39
[patent_figures_cnt] => 39
[patent_no_of_words] => 35262
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 22
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14776835
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/776835 | ACTIVATING AN ALTERNATIVE PATHWAY FOR HOMOLOGY-DIRECTED REPAIR TO STIMULATE TARGETED GENE CORRECTION AND GENOME ENGINEERING | Apr 15, 2014 | Abandoned |
Array
(
[id] => 13251571
[patent_doc_number] => 10138467
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-11-27
[patent_title] => Medium for high performance mammalian fed-batch cultures
[patent_app_type] => utility
[patent_app_number] => 15/028989
[patent_app_country] => US
[patent_app_date] => 2014-04-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 9139
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 280
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15028989
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/028989 | Medium for high performance mammalian fed-batch cultures | Apr 2, 2014 | Issued |
Array
(
[id] => 9720346
[patent_doc_number] => 20140256046
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-09-11
[patent_title] => 'ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR SEQUENCE MANIPULATION WITH FUNCTIONAL DOMAINS'
[patent_app_type] => utility
[patent_app_number] => 14/226274
[patent_app_country] => US
[patent_app_date] => 2014-03-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 49
[patent_figures_cnt] => 49
[patent_no_of_words] => 39437
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14226274
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/226274 | Engineering and optimization of systems, methods and compositions for sequence manipulation with functional domains | Mar 25, 2014 | Issued |
Array
(
[id] => 9685934
[patent_doc_number] => 20140242700
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-08-28
[patent_title] => 'ENGINEERING AND OPTIMIZATION OF IMPROVED SYSTEMS, METHODS AND ENZYME COMPOSITIONS FOR SEQUENCE MANIPULATION'
[patent_app_type] => utility
[patent_app_number] => 14/222930
[patent_app_country] => US
[patent_app_date] => 2014-03-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 119
[patent_figures_cnt] => 119
[patent_no_of_words] => 42266
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14222930
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/222930 | Engineering and optimization of improved systems, methods and enzyme compositions for sequence manipulation | Mar 23, 2014 | Issued |
Array
(
[id] => 9757237
[patent_doc_number] => 20140287938
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-09-25
[patent_title] => 'RECOMBINANT VIRUS AND PREPARATIONS THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/213991
[patent_app_country] => US
[patent_app_date] => 2014-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 57
[patent_figures_cnt] => 57
[patent_no_of_words] => 37538
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14213991
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/213991 | Recombinant virus and preparations thereof | Mar 13, 2014 | Issued |
Array
(
[id] => 10799472
[patent_doc_number] => 20160145630
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-05-26
[patent_title] => 'COMPOSITIONS AND METHODS FOR THE IMPROVED PRODUCTION AND DELIVERY OF RNA BY EFFICIENT TRANSCRIPTION TERMINATION'
[patent_app_type] => utility
[patent_app_number] => 14/901003
[patent_app_country] => US
[patent_app_date] => 2014-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 28344
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14901003
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/901003 | Compositions and methods for the improved production and delivery of RNA by efficient transcription termination | Mar 12, 2014 | Issued |
Array
(
[id] => 9737372
[patent_doc_number] => 20140273090
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-09-18
[patent_title] => 'Methods and Systems for Peptide/Protein Amplification'
[patent_app_type] => utility
[patent_app_number] => 14/207003
[patent_app_country] => US
[patent_app_date] => 2014-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 4753
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14207003
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/207003 | Methods and Systems for Peptide/Protein Amplification | Mar 11, 2014 | Abandoned |
Array
(
[id] => 9737507
[patent_doc_number] => 20140273225
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-09-18
[patent_title] => 'NUCLEOSOME-EXCLUDING SEQUENCES (NES) AS A DNA SPACER IN VECTORS RESULTS IN PROLONGED TRANSGENE EXPRESSION IN EUKARYOTIC CELLS'
[patent_app_type] => utility
[patent_app_number] => 14/205008
[patent_app_country] => US
[patent_app_date] => 2014-03-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 10532
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14205008
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/205008 | Nucleosome-excluding sequences (NES) as a DNA spacer in vectors results in prolonged transgene expression in eukaryotic cells | Mar 10, 2014 | Issued |
Array
(
[id] => 12946165
[patent_doc_number] => 09834765
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-12-05
[patent_title] => Sequence tags
[patent_app_type] => utility
[patent_app_number] => 14/200325
[patent_app_country] => US
[patent_app_date] => 2014-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 6140
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 234
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14200325
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/200325 | Sequence tags | Mar 6, 2014 | Issued |
Array
(
[id] => 10700856
[patent_doc_number] => 20160047003
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-02-18
[patent_title] => 'HIGH THROUGHPUT METHOD OF SCREENING A POPULATION FOR MEMBERS COMPRISING MUTATION(S) IN A TARGET SEQUENCE'
[patent_app_type] => utility
[patent_app_number] => 14/773643
[patent_app_country] => US
[patent_app_date] => 2014-03-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 10083
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14773643
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/773643 | HIGH THROUGHPUT METHOD OF SCREENING A POPULATION FOR MEMBERS COMPRISING MUTATION(S) IN A TARGET SEQUENCE | Mar 5, 2014 | Abandoned |
Array
(
[id] => 9869272
[patent_doc_number] => 08957044
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-02-17
[patent_title] => 'Systemic gene replacement therapy for treatment of X-linked myotubular myopathy (XLMTM)'
[patent_app_type] => utility
[patent_app_number] => 14/194186
[patent_app_country] => US
[patent_app_date] => 2014-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 34
[patent_no_of_words] => 31200
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14194186
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/194186 | Systemic gene replacement therapy for treatment of X-linked myotubular myopathy (XLMTM) | Feb 27, 2014 | Issued |
Array
(
[id] => 11102154
[patent_doc_number] => 20160299124
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-10-13
[patent_title] => 'BLOOD STATE ANALYSIS DEVICE, BLOOD STATE ANALYSIS SYSTEM, BLOOD STATE ANALYSIS METHOD, AND PROGRAM'
[patent_app_type] => utility
[patent_app_number] => 14/777906
[patent_app_country] => US
[patent_app_date] => 2014-02-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 7311
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14777906
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/777906 | Blood state analysis device, blood state analysis system, blood state analysis method, and program | Feb 17, 2014 | Issued |
Array
(
[id] => 10863662
[patent_doc_number] => 08889356
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-11-18
[patent_title] => 'CRISPR-Cas nickase systems, methods and compositions for sequence manipulation in eukaryotes'
[patent_app_type] => utility
[patent_app_number] => 14/183471
[patent_app_country] => US
[patent_app_date] => 2014-02-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 116
[patent_figures_cnt] => 117
[patent_no_of_words] => 52642
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 108
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14183471
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/183471 | CRISPR-Cas nickase systems, methods and compositions for sequence manipulation in eukaryotes | Feb 17, 2014 | Issued |